Primary Image

violet background with white rectangles

Clinical Trial

Effects of twice-daily dosing 4-AP on Functional Recovery after Spinal Cord Injury

IRB Protocol Number STU00221545

Contact

Bing Chen bchen03@sralab.org

Objective

Our studies aim to investigate potential Neuro-modulation Therapies with the help of an FDA approved drug in individuals with spinal cord injuries

Your participation will involve a non-invasive, and painless way to stimulate persons with spinal cord injuries, while muscle activity is observed and recorded.

Participants could participate in trials involving:

  • Non-invasive Brain Stimulation
  • Spinal Cord Stimulation
  • Exercise Training
  • Flexible Schedules

Who Can Participate

  • Spinal cord injury between C2–L2  
  • At least 6 months post-injury
  • Complete or incomplete
  • Male or female

Compensation

Opportunities for Compensation

Age Range

18-85

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies

Share Your Experience Flying with a Physical Disability

Researchers at Shirley Ryan 外网天堂, Northwestern University, and Indiana University are conducting two research studies to understand the challenges people with physical disabilities face during air travel, as well as the factors that could improve their travel experience and help airlines and airports become more inclusive and accessible.

read more
view all

Latest Updates

view all